Michelle Blake

MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis

Katya Marjon, Michael J. Cameron, Phong Quang et al. · Cell Reports · 2016 · 447 citations · Full text

Medicine, Cancer Biology, Oncology +17

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

Damian J. Green, Margot J. Pont, Blythe Sather et al. · Blood · 2018 · 129 citations

Life Sciences, Immunology, Oncology +14

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Sham Mailankody, Myo Htut, Kelvin P. Lee et al. · Blood · 2018 · 124 citations

Medicine, Hematology, Oncology +16

Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma

Andrew J. Cowan, Margot J. Pont, Blythe Sather et al. · Blood · 2019 · 64 citations

Life Sciences, Immunology, Oncology +16

RANK expression on breast cancer cells promotes skeletal metastasis

Michelle Blake, Mark Tometsko, Robert E. Miller et al. · Clinical & Experimental Metastasis · 2013 · 57 citations

Medicine, Cancer Biology, Cell Biology +16